Wellington Management Group LLP 13D and 13G filings for Structure Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Structure Therapeutics Inc. GPCR |
Wellington Management Group LLP | 23,309,313 13.950% |
10,192,335![]() (+77.70%) |
Filing |
2024-02-08 10:03 am Sale |
2023-12-29 | 13G | Structure Therapeutics Inc. GPCR |
Wellington Management Group LLP | 13,116,978 9.430% |
-2,763,258![]() (-17.40%) |
Filing |
2024-02-06 11:01 am Purchase |
2024-01-31 | 13G | Structure Therapeutics Inc. GPCR |
Wellington Management Group LLP | 15,880,236 11.410% |
15,880,236![]() (New Position) |
Filing |